MedTrace Logo

Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

NCT02597855 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2016-08-18

Study results available
· View outcomes & findings →

Summary

To compare the short-term effect of intravitreal aflibercept injection between two subtypes of polypoidal choroidal vasculopathy

Conditions

  • Polypoidal Choroidal Vasculopathy

Interventions

DRUG

Aflibercept

Total 4 times of intravitreal aflibercept injection was performed

DRUG

Indocyanine green angiography (intraveonus indocyanine green dye)

At initial visit, indocyanine green angiography was performed. After 1 month of third Aflibercept injection, indocyanine green angiography was performed to evaluate polyp closure.

Sponsors & Collaborators

  • Yeungnam University College of Medicine

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-12-31
Completion
2016-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597855 on ClinicalTrials.gov